OTG Acquisition Corp. I
Filed Aug 25, 2025.
View on SEC.govAbout this filing
A company's registration of shares for sale to the public, often for a first offering. It describes the business, its risks and how the company plans to use the money.
period unavailable · Filed Aug 25, 2025
Contents
Cover page
Show cover page
S-11 forms-1.htm S-1
As filed with the U.S. Securities and Exchange Commission on August 22, 2025.
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
OTG Acquisition Corp. I
(Exact name of registrant as specified in its charter)
| Cayman Islands | 6770 | 98-1868600 |
|---|---|---|
| (State or other jurisdiction of incorporation or organization) | (Primary Standard Industrial Classification Code Number) | (I.R.S. Employer Identification No.) |
12003 Cielo Court
Palm Beach Gardens, Florida 33418
Tel.: (917) 488-5629
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Scott Troeller
12003 Cielo Court
Palm Beach Gardens, Florida 33418
Tel.: (917) 488-5629
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
| Daniel L. Forman Lowenstein Sandler LLP 1251 Avenue of the Americas New York, New York 10022 Tel.: (212) 262-6700 | Jason Allison Walkers (Cayman) LLP 190 Elgin Avenue George Town, Grand Cayman KY1-9001, Cayman Islands Tel.: (345) 914 6358 | Joel L. Rubinstein Daniel E. Nussen White & Case LLP 1221 Avenue of the Americas New York, New York 10020 Tel.: (212) 819-8200 |
|---|
**Approximate date of commencement of proposed sale to the public:**As soon as practicable after the effective date of this registration statement.
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☐
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Securities Exchange Act of 1934.
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
|---|---|---|---|
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
| Emerging growth company | ☒ | ||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
The registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until this Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.
The information in this preliminary prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the U.S. Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
SUBJECT TO COMPLETION, DATED AUGUST 22, 2025
PRELIMINARY PROSPECTUS
$200,000,000
OTG Acquisition Corp. I
20,000,000 Units
OTG Acquisition Corp. I is a newly organized blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which we refer to as our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target.
This is an initial public offering of our securities. Each unit has an offering price of $10.00 and consists of one Class A ordinary share, par value $0.0001, and one-half of one redeemable warrant. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Accordingly, unless you purchase two public units, you will not be able to receive or trade a whole warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment, terms and limitations as described herein. The warrants will become exercisable 30 days after the completion of our initial business combination, and will expire five years after the completion of our initial business combination or earlier upon redemption or liquidation of the company, as described in this prospectus. Subject to the terms and conditions described in this prospectus, we may redeem the warrants for cash once the warrants become exercisable. The underwriters have a 45-day option from the date of this prospectus to purchase up to 3,000,000 additional public units to cover over-allotments, if any.
We will provide our public shareholders with the opportunity to redeem, regardless of whether they abstain, vote for, or vote against, our initial business combination, all or a portion of their Class A ordinary shares that were sold as part of the units in this offering, which we refer to collectively as our public shares, upon the completion of our initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in our trust account calculated as of two business days prior to the consummation of the initial business combination, including interest earned on the funds held in the trust account (net of amounts withdrawn or eligible to be withdrawn to pay our taxes (which shall exclude the 1% U.S. federal excise tax that was implemented by the Inflation Reduction Act of 2022 if any is imposed on us), which we refer to as permitted withdrawals), divided by the number of then-issued and outstanding public shares, subject to applicable law and limitation and on the conditions described herein. As further described in this prospectus, our amended and restated memorandum and articles of association will provide that a public shareholder, together with any affiliate or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its public shares with respect to more than an aggregate of 20% of the public shares sold in this offering, without our prior consent. If we do not consummate an initial business combination within 24 months from the closing of this offering (as may be extended by shareholder approval to amend our amended and restated memorandum and articles of association) or our board of directors approves an earlier liquidation, we will redeem 100% of the public shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released to us for permitted withdrawals (less up to $100,000 of interest to pay dissolution expenses), divided by the number of the then issued and outstanding public shares, subject to applicable law and certain conditions as further described herein. We may seek shareholder approval to amend our amended and restated memorandum and articles of association to extend the date by which we must consummate our initial business combination. If we seek shareholder approval for an extension, and the related amendments are approved by a special resolution of the shareholders, holders of our public shares will be offered an opportunity to redeem their shares in connection with the implementation of any such amendment. Redemption rights may also be available to shareholders in certain other circumstances as described herein and in our amended and restated memorandum and articles of association.
Our sponsor, OTG Acquisition Sponsor LLC, and the underwriters in this offering, have agreed to purchase an aggregate of 700,000 private placement units (or up to 775,000 private placement units if the underwriters’ over-allotment option is exercised in full), at a price of $10.00 per unit, for an aggregate purchase price of $7,000,000 (or up to $7,750,000 if the underwriters’ over-allotment option is exercised in full) in a private placement that will close simultaneously with the closing of this offering. Of these private placement units, our sponsor has agreed to purchase 500,000 private placement units (or 545,000 private placement units if the over-allotment option is exercised in full) and the underwriters have agreed to purchase 200,000 private placement units (or 230,000 private placement units if the over-allotment option is exercised in full). We refer to these units throughout this prospectus as the private placement units. Each private placement warrant is exercisable to purchase one whole Class A ordinary share at a price of $11.50 per share, subject to adjustment, terms and limitations as described herein. The private placement warrants are identical to the warrants sold in this offering, subject to certain limited exceptions, as described in this prospectus. None of the private placement warrants will be redeemable by us. For so long as they are held by the underwriters or their affiliates or associated persons, the private placement warrants will not be exercisable more than five years from the consummation of sales in this offering in accordance with FINRA rules. Each private placement share included in each private placement unit will not have any redemption rights or be entitled to liquidating distributions from the trust account if we fail to consummate an initial business combination.
Further, our sponsor currently owns an aggregate of 5,750,000 of our Class B ordinary shares, par value $0.0001 per share (up to 750,000 of which are subject to forfeiture), which will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation of our initial business combination or earlier at the option of the holder on a one-for-one basis (such Class A ordinary shares delivered upon conversion will not have any redemption rights or be entitled to liquidating distributions from the trust account if we fail to consummate an initial business combination), subject to adjustment as described herein. If we increase or decrease the size of this offering, we will effect a share capitalization or a share surrender or redemption and cancellation or other appropriate mechanism, as applicable, with respect to our Class B ordinary shares immediately prior to the consummation of this offering in such amount as to maintain the ownership of our sponsor (and its permitted transferees), on an as-converted basis, at 20% of our issued and outstanding ordinary shares (excluding the private placement shares included in the private placement units) upon the consummation of this offering.
Prior to the completion of our initial business combination, only holders of our Class B ordinary shares will be entitled to vote on the election of directors or in a vote to transfer the company by way of continuation to a jurisdiction outside the Cayman Islands. With respect to any other matter submitted to a vote of our shareholders, including any vote in connection with our initial business combination, except as required by law or the applicable rules of Nasdaq then in effect, holders of our founder shares and holders of our public shares will vote together as a single class, with each share entitling the holder to one vote. The founder shares held by our sponsor were purchased for $25,000, or approximately $0.004 per share, which, as further described in this prospectus, may result in material dilution to public holders when converted into Class A ordinary shares or if the anti-dilution provision of the founder shares results in the issuance of Class A ordinary shares on a greater than one-to-one basis (for more information on dilution, also see the section entitled “*Dilution”*in this prospectus). As further described under “Offering—Other Considerations and Conflicts of Interest—Compensation of Sponsor, Sponsor’s Affiliates and Directors and Officers,” we expect to make certain payments and reimbursements, or pay certain fees, to our sponsor, officers or directors, or our or their affiliates, including but not limited to the payment of $20,000 per month to Expedition Infrastructure Partners, LLC, of which our Chief Executive Officer is co-founder and managing partner, or an affiliate thereof for office space, secretarial and administrative services. Our sponsor, sponsor’s affiliates and our directors or officers may also, but are not obligated to, enter into certain arrangements with us to finance transaction costs in connection with an initial business combination, including up to $1,500,000 of loans convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. As more fully discussed in the section of this prospectus entitled “Management—Conflicts of Interest,” our officers and directors currently have certain relevant fiduciary duties or contractual obligations that may take priority over their duties to us and there may be a conflict of interest in our director’s and officer’s determination as to how much time to devote to our affairs and to which entity a particular business opportunity is presented. We may also decide to acquire one or more businesses affiliated with our sponsor or our executive officers or directors, or our directors, officers, sponsor and their affiliates may sponsor or become affiliated with entities that have a similar activity to ours. Further, our officers and directors have indirect economic interests in us and/or our sponsor and a conflict of interest may arise in determining whether a particular business combination target is appropriate for our initial business combination and in negotiating or accepting the terms of the transaction since our sponsor, executive officers and directors may lose their entire investment in us if an initial business combination is not completed. The low price that our sponsor paid for the founder shares creates an incentive whereby certain of our officers and directors who hold membership interests in our sponsor could potentially make a substantial profit even if we select an acquisition target that subsequently declines in value and is unprofitable for public shareholders. If we do not complete our initial business combination within 24 months from the closing of this offering (as may be extended by shareholder approval to amend our amended and restated memorandum and articles of association), the founder shares and private placement units held by our sponsor may lose most of their value, except to the extent that the founder shares or the Class A ordinary shares included in the private placement units receive liquidating distributions from assets outside the trust account, which could create an incentive for our sponsor, executive officers and directors to complete a transaction even if we select an acquisition target that subsequently declines in value and is unprofitable for public shareholders. As a result, there may be actual or potential material conflicts of interest between our sponsor and its affiliates on the one hand, and purchasers in this offering on the other hand. For more information, including about our sponsor’s and our affiliates’ securities and compensation, also see “Summary—Other Considerations and Conflicts of Interest,” “The Offering—Founder shares,’’ “The Offering—Transfer restrictions on founder shares and private placement units,’’ “The Offering—Appointment of Directors; Voting Rights,’’ “Risk Factors—Risks Relating to Our Securities – The nominal purchase price paid by our sponsor and our directors for the founder shares may significantly dilute the implied value of your public shares in the event we consummate an initial business combination, and our sponsor is likely to make a substantial profit on its investment in us in the event we consummate an initial business combination, even if the business combination causes the trading price of our Class A ordinary shares to materially decline,’’ “Risk Factors—Risks Relating to our Sponsor and Management Team’’ and “Principal Shareholders.”
The following table illustrates the difference between the public offering price and our net tangible book value per share, as adjusted to reflect various potential redemption levels that may occur in connection with the closing of our initial business combination, which we refer to as Adjusted NTBVPS, on a pro forma basis to give effect to this offering and the issuance of the private placement units, assuming no exercise of the over-allotment option and exercise of the over-allotment option in full. Adjusted NTBVPS excludes the effect of the consummation of our initial business combination or any related transactions or expenses. See section entitled “*Dilution”*for more information.
| AS OF JUNE 18, 2025 | ||||||||
|---|---|---|---|---|---|---|---|---|
| OFFERING PRICE OF $10.00 · 25% OF MAXIMUM REDEMPTION · 50% OF MAXIMUM REDEMPTION · 75% OF MAXIMUM REDEMPTION · MAXIMUM REDEMPTION | ||||||||
| ADJUSTED NTBVPS | ADJUSTED NTBVPS | DIFFERENCE BETWEEN ADJUSTED NTBV AND OFFERING PRICE | ADJUSTED NTBVPS | DIFFERENCE BETWEEN ADJUSTED NTBV AND OFFERING PRICE | ADJUSTED NTBVPS | DIFFERENCE BETWEEN ADJUSTED NTBV AND OFFERING PRICE | ADJUSTED NTBVPS | DIFFERENCE BETWEEN ADJUSTED NTBV AND OFFERING PRICE |
| Assuming Full Exercise of Over-Allotment Option | ||||||||
| $7.87 | $7.35 | $2.65 | $6.48 | $3.52 | $4.81 | $5.19 | $0.20 | $9.80 |
| Assuming No Exercise of Over-Allotment Option | ||||||||
| $7.86 | $7.34 | $2.66 | $6.47 | $3.53 | $4.80 | $5.20 | $0.19 | $9.81 |
Currently, there is no public market for our units, Class A ordinary shares or warrants. We have applied to list on Nasdaq Global Market, or Nasdaq, under the symbol “OTGAU.” We expect that the Class A ordinary shares and warrants comprising the units will begin separate trading on Nasdaq under the symbols “OTGA” and “OTGAW,” respectively, on the 52nd day following the date of this prospectus (or, if such date is not a business day, the following business day) unless B. Riley Securities, Inc. (“B. Riley”) permits earlier separate trading and we have satisfied certain conditions.
We are an “emerging growth company” and “smaller reporting company” under applicable federal securities laws and will be subject to reduced public company reporting requirements. Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page 38 for a discussion of information that should be considered in connection with an investment in our securities. Investors will not be entitled to protections normally afforded to investors in Rule 419 blank check offerings.
Neither the U.S. Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
No offer or invitation, whether directly or indirectly, may be made to the public in the Cayman Islands to subscribe for our securities.
| PER UNIT | TOTAL | |
|---|---|---|
| Public offering price | $10.00 | $200,000,000 |
| Underwriting discounts and commissions (1) | $0.20 | $4,000,000 |
| Proceeds, before expenses, to us | $9.80 | $196,000,000 |
| (1) | The underwriters will receive compensation in addition to the underwriting discount. See “Underwriting” for a description of the compensation and other items of value payable to the underwriters. |
Of the proceeds we receive from this offering and the sale of the private placement units described in this prospectus, $201,000,000, or $231,150,000 if the underwriters’ over-allotment option is exercised in full ($10.05 per unit in either case), will be deposited into a trust account located in the United States with Continental Stock Transfer & Trust Company acting as trustee.
The underwriters are offering the units for sale on a firm commitment basis. The underwriters expect to deliver the units to the purchasers on or about , 2025.
Lead * Book-Running Manager*
B. Riley Securities
Joint Book-Runners*
Northland Capital Markets ** ** Lake Street
, 2025
TABLE OF CONTENTS
| PAGES | |
|---|---|
| SUMMARY | 1 |
| RISKS | 38 |
| SUMMARY FINANCIAL DATA | 40 |
| CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS | 91 |
| USE OF PROCEEDS | 92 |
| DIVIDEND POLICY | 95 |
| DILUTION | 96 |
| CAPITALIZATION | 100 |
| MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS | 101 |
| PROPOSED BUSINESS | 106 |
| EFFECTING OUR INITIAL BUSINESS COMBINATION | 121 |
| MANAGEMENT | 139 |
| PRINCIPAL SHAREHOLDERS | 148 |
| CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS | 151 |
| DESCRIPTION OF SECURITIES | 153 |
| SECURITIES ELIGIBLE FOR FUTURE SALE | 175 |
| TAXATION | 179 |
| UNDERWRITING | 191 |
| LEGAL MATTERS | 202 |
| EXPERTS | 202 |
| WHERE YOU CAN FIND ADDITIONAL INFORMATION | 202 |
| EXHIBIT INDEX | II-3 |
We are responsible for the information contained in this prospectus. We have not authorized anyone to provide you with different information, and neither we nor the underwriters take any responsibility for any other information others may give to you. We are not, and the underwriters are not, making an offer to sell securities in any jurisdiction where the offer or sale is not permitted. You should not assume that the information contained in this prospectus is accurate as of any date other than the date on the front of this prospectus.
i
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.